Reduction in mortality from HIV-related CNS infections in routine care in Africa (DREAMM): a before-and-after, implementation study

Reduction in mortality from HIV-related CNS infections in routine care in Africa (DREAMM): a before-and-after, implementation study

<p><strong>Background</strong></p> Four decades into the HIV epidemic, CNS infection remains a leading cause of preventable HIV-related deaths in routine care. The Driving Reduced AIDS-associated Meningo-encephalitis Mortality (DREAMM) project aimed to develop, implement, and...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Mfinanga, S, Kanyama, C, Kouanfack, C, Fuller, S
Rannpháirtithe:	DREAMM Consortium
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	Elsevier 2023

Míreanna comhchosúla

Patient-reported experiences during and following treatment with belantamab mafodotin for relapsed/refractory multiple myeloma in the DREAMM-2 study
de réir: Anna Cardellino, et al.
Foilsithe / Cruthaithe: (2023-12-01)

P940: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-4 STUDY
de réir: A. Suvannasankha, et al.
Foilsithe / Cruthaithe: (2022-06-01)

Scaling up integrated care for HIV and other chronic conditions in routine health care settings in sub-Saharan Africa: Field notes from Uganda
de réir: Faith Moyo, et al.
Foilsithe / Cruthaithe: (2023-08-01)

P942: DREAMM-9: PHASE I STUDY OF BELANTAMAB MAFODOTIN PLUS STANDARD OF CARE IN PATIENTS WITH TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA
de réir: S. Z. Usmani, et al.
Foilsithe / Cruthaithe: (2022-06-01)

CNS Involvement in HIV Infection
de réir: J Gordon Millichap
Foilsithe / Cruthaithe: (1991-08-01)

Dreamm-4: evaluating safety and clinical activity of belantamab mafodotin (belamaf) in combination with pembrolizumab in patients with relapsed/refractory multiple myeloma (rrmm)
de réir: A. Medaglia, et al.
Foilsithe / Cruthaithe: (2020-09-01)

P31 SINGLE-AGENT BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA: FINAL ANALYSIS OF THE DREAMM-2 TRIAL
de réir: A. Nooka, et al.
Foilsithe / Cruthaithe: (2023-05-01)

Integrating hepatitis C testing and treatment into routine HIV care in Cameroon is feasible
de réir: Mathurin Pierre Kowo, et al.
Foilsithe / Cruthaithe: (2025-02-01)

Impact of prolonged dose delays on response with belantamab mafodotin (belamaf; gsk2857916) treatment in dreamm-2 study: 13-month follow-up
de réir: A. Medaglia, et al.
Foilsithe / Cruthaithe: (2020-09-01)

Implementing routine HIV testing: the role of state law.
de réir: Leslie E Wolf, et al.
Foilsithe / Cruthaithe: (2007-01-01)

Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody–Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study
de réir: Asim V. Farooq, et al.
Foilsithe / Cruthaithe: (2020-07-01)

Longitudinal CNS and systemic T-lymphocyte and monocyte activation before and after antiretroviral therapy beginning in primary HIV infection
de réir: Phillip Chan, et al.
Foilsithe / Cruthaithe: (2025-02-01)

P864: A PHASE 1 STUDY OF BELANTAMAB MAFODOTIN IN COMBINATION WITH STANDARD OF CARE IN NEWLY DIAGNOSED MULTIPLE MYELOMA: AN INTERIM ANALYSIS OF DREAMM-9
de réir: Saad Z Usmani, et al.
Foilsithe / Cruthaithe: (2023-08-01)

P14: DREAMM-9: PHASE I STUDY OF BELANTAMAB MAFODOTIN PLUS STANDARD OF CARE IN PATIENTS WITH TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA
de réir: S Usmani, et al.
Foilsithe / Cruthaithe: (2022-04-01)

PB2022: EXPLORING ALTERNATIVE DOSING REGIMENS OF SINGLE-AGENT BELANTAMAB MAFODOTIN ON SAFETY AND EFFICACY IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA: DREAMM-14
de réir: M. Hultcrantz, et al.
Foilsithe / Cruthaithe: (2022-06-01)

P983: DREAMM-20: A STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF BELANTAMAB FOR THE TREATMENT OF MULTIPLE MYELOMA WHEN USED AS MONOTHERAPY AND IN COMBINATION TREATMENTS
de réir: Hang Quach, et al.
Foilsithe / Cruthaithe: (2023-08-01)

Correction to: Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody–Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study
de réir: Asim V. Farooq, et al.
Foilsithe / Cruthaithe: (2020-09-01)

Viral infections of the CNS in sub-Saharan Africa: interaction with Plasmodium falciparum.
de réir: Newton, C
Foilsithe / Cruthaithe: (2013)

Pilot implementation of two specific problem lists before and after solid organ transplantation into routine care
de réir: Sanna Higgen, et al.
Foilsithe / Cruthaithe: (2025-01-01)

MORTALITY BEFORE AND AFTER HIV-INFECTION IN THE COMPLETE UK POPULATION OF HEMOPHILIACS
de réir: Darby, S, et al.
Foilsithe / Cruthaithe: (1995)

Challenging new targets for CNS–HIV infection
de réir: Ganau, M, et al.
Foilsithe / Cruthaithe: (2012)

Challenging new targets for CNS-HIV infection
de réir: Mario eGanau, et al.
Foilsithe / Cruthaithe: (2012-03-01)

Dreamm-2: single-agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma (rrmm), including subgroups with renal impairment (ri) and high-risk (hr) cytogenetics
de réir: S. Lonial, et al.
Foilsithe / Cruthaithe: (2020-09-01)

Mortality and loss to programme before antiretroviral therapy among HIV-infected children eligible for treatment in The Gambia, West Africa
de réir: Okomo Uduak, et al.
Foilsithe / Cruthaithe: (2012-10-01)

Fungal CNS Infections in Africa: The Neuroimmunology of Cryptococcal Meningitis
de réir: Sally H. Mohamed, et al.
Foilsithe / Cruthaithe: (2022-04-01)

HIV viral transcription and immune perturbations in the CNS of people with HIV despite ART
de réir: Shelli F. Farhadian, et al.
Foilsithe / Cruthaithe: (2022-07-01)

Results from Arm A of Phase 1/2 DREAMM-6 trial: belantamab mafodotin with lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma
de réir: Rakesh Popat, et al.
Foilsithe / Cruthaithe: (2024-10-01)

P941: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH LENALIDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-6 ARM-A INTERIM ANALYSIS
de réir: H. Quach, et al.
Foilsithe / Cruthaithe: (2022-06-01)

Use of Trained Non-Medical Staff to Improve Access to HIV Testing Services in Africa: Implementation of the World Health Organization Opt-out Approach in Cameroon
de réir: Charles Kouanfack, et al.
Foilsithe / Cruthaithe: (2021-04-01)

Phylogenetic position and genetic features of HIV-1 in CNS
de réir: Mikhail V. Piterskiy, et al.
Foilsithe / Cruthaithe: (2024-03-01)

Neuroimmunology of CNS HIV Infection: A Narrative Review
de réir: Ana-Claire Meyer, et al.
Foilsithe / Cruthaithe: (2022-06-01)

Capturing the spatial variability of HIV epidemics in South Africa and Tanzania using routine healthcare facility data
de réir: Cuadros, DF, et al.
Foilsithe / Cruthaithe: (2018)

P939: SYNERGISTIC EFFECTS OF LOW DOSE BELANTAMAB MAFODOTIN IN COMBINATION WITH A GAMMA-SECRETASE INHIBITOR (NIROGACESTAT) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-5 STUDY
de réir: A. Nooka, et al.
Foilsithe / Cruthaithe: (2022-06-01)

Molecular chlamydia and gonorrhoea point of care tests implemented into routine practice: systematic review and value proposition development
de réir: Fuller, SS, et al.
Foilsithe / Cruthaithe: (2021)

The 4-Year Experience with Implementation and Routine Use of Pathogen Reduction in a Brazilian Hospital
de réir: Roberta Maria Fachini, et al.
Foilsithe / Cruthaithe: (2021-11-01)

Molecular chlamydia and gonorrhoea point of care tests implemented into routine practice: Systematic review and value proposition development.
de réir: Sebastian S Fuller, et al.
Foilsithe / Cruthaithe: (2021-01-01)

Molecular chlamydia and gonorrhoea point of care tests implemented into routine practice: Systematic review and value proposition development
de réir: Sebastian S. Fuller, et al.
Foilsithe / Cruthaithe: (2021-01-01)

Crossroads of Drug Abuse and HIV Infection: Neurotoxicity and CNS Reservoir
de réir: Shilpa Sonti, et al.
Foilsithe / Cruthaithe: (2022-01-01)

HIV-1 sequence compartmentalisation and evolution in CNS and immune tissue
de réir: M. Gonzalez-Perez, et al.
Foilsithe / Cruthaithe: (2019-12-01)

Spatial patterns of fetal mortality: scenario before and after the implementation of surveillance
de réir: Maria Carolina Lyra da Silva, et al.
Foilsithe / Cruthaithe: (2021-10-01)